Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment

Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment

Aim: This study focusses on the anti-inflammatory and immune-modulatory roles of berberine (BBR) in ulcerative colitis (UC) treatment. Additionally, the underlying mechanisms of BBR were systematically explored. Methods: A 3% (w/v) dextran sodium sulphate (DSS) solution was used for establishing the...

Full description

Bibliographic Details
Main Authors:	Kai Xiong, Jia Deng, Tinghui Yue, Wenting Hu, Xinglin Zeng, Tao Yang, Tianbao Xiao
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Heliyon
Subjects:	Ulcerative colitis Berberine Inflammation Macrophages
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402301383X

Similar Items

Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy
by: Xiaofan Xu, et al.
Published: (2022-07-01)

Berberine-loaded PLGA nanoparticles alleviate ulcerative colitis by targeting IL-6/IL-6R axis
by: Chao Liu, et al.
Published: (2024-10-01)

Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures
by: Yida Xu, et al.
Published: (2024-09-01)

Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model
by: Chang C, et al.
Published: (2024-02-01)

Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota
by: Chenyang Wu, et al.
Published: (2022-09-01)

Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer
by: Maorun Zhang, et al.
Published: (2023-03-01)

Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora
by: Yifan Feng, et al.
Published: (2023-06-01)

Comprehensive plasma metabolomics analysis of berberine treatment in ulcerative colitis rats by LC-MS/MS
by: Baodong Feng, et al.
Published: (2024-12-01)

Change of monocytes/macrophages in ulcerative colitis patients with symptoms of anxiety and depression
by: Xin Gao, et al.
Published: (2023-03-01)

Macrophages in ulcerative colitis: A perspective from bibliometric and visual analysis
by: Lijiang Ji, et al.
Published: (2023-09-01)

Multi-omics reveals the alleviating effect of berberine on ulcerative colitis through modulating the gut microbiome and bile acid metabolism in the gut-liver axis
by: Jingsheng Yu, et al.
Published: (2024-10-01)

Berberine attenuates TNBS-induced colitis in mice by improving the intestinal microbiota
by: Chao Li, et al.
Published: (2024-08-01)

Integrating single-cell RNA-Seq and machine learning to dissect tryptophan metabolism in ulcerative colitis
by: Guorong Chen, et al.
Published: (2024-12-01)

A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals
by: Ke Wang, et al.
Published: (2023-05-01)

Anti-Inflammatory Effects of Zinc Oxide and Berberine in Rats with Dextran Sulfate Sodium (DSS)-Induced Colitis
by: Seon-Hyoung Kim, et al.
Published: (2024-06-01)

GRK2 Mediates Macrophage Polarization by Regulating EP4-cAMP-pCREB Signaling in Ulcerative Colitis and the Therapeutic Effect of Paroxetine on Mice with DSS-Induced Colitis
by: Jiawei Zhang, et al.
Published: (2023-04-01)

Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation
by: Li J, et al.
Published: (2024-07-01)

Protective Effect of Berberine on Acute Gastric Ulcer by Promotion of Tricarboxylic Acid Cycle-Mediated Arachidonic Acid Metabolism
by: Guo Q, et al.
Published: (2024-01-01)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01)

Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages
by: Shwe Phyu Hlaing, et al.
Published: (2022-10-01)

HMGB1 Modulates Macrophage Metabolism and Polarization in Ulcerative Colitis by Inhibiting Cpt1a Expression
by: Fenfen Wang, et al.
Published: (2024-11-01)

Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01)

Current and Emerging Biologics for Ulcerative Colitis
Published: (2015-01-01)

Oral cyclodextrin supramolecular for ulcerative colitis treatment through macrophages targeting / ROS response-based accurate on-demand drug release strategy
by: Haiting Xu, et al.
Published: (2023-02-01)

Prevalence of Entamoeba Histolytica infection in patients with colitis (Ulcerative and Infective)
by: Luay I. Farhan Al-Rwi, et al.
Published: (2016-10-01)

Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01)

Acetylation of p65Lys310 by p300 in macrophages mediates anti-inflammatory property of berberine
by: Shuchen Zhang, et al.
Published: (2023-06-01)

The evolving understanding of histology as an endpoint in ulcerative colitis
by: Shintaro Akiyama, et al.
Published: (2024-10-01)

Anti-integrin treatment as an effective alternative for a patient with ulcerative colitis
by: Ewa Biegańska, et al.
Published: (2022-12-01)

Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
by: Jesus K. Yamamoto-Furusho, et al.
Published: (2025-01-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2020-01-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2019-01-01)

Ulcerative colitis – recent and potential methods of treatment - review
by: Mikołaj Tomasik, et al.
Published: (2023-01-01)

Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”
by: Danusia Onisor, et al.
Published: (2024-08-01)

Is Infection Associated With Ulcerative Colitis Activity?
by: Ayoung Lee, et al.
Published: (2024-03-01)

Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
by: Hiroaki Kitae, et al.
Published: (2022-05-01)

Cell-penetrating TLR inhibitor peptide alleviates ulcerative colitis by the functional modulation of macrophages
by: Bikash Thapa, et al.
Published: (2023-05-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Concomitant occurrence of appendiceal mucocele and ulcerative colitis: Case reports
by: Hafez Fakheri, et al.
Published: (2023-03-01)

Ulcerative Colitis and Neopterin: Related?
by: Beşir Kesici, et al.
Published: (2019-04-01)